GlobalData on MSN14h
Replicate’s rabies vaccine rivals Bavarian Nordic’s RavAlert at Phase I
The US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.
Malaysian Reserve20h
Most patients on Lilly’s Omvoh® (mirikizumab-mrkz) for Crohn’s disease achieved sustained clinical remission and endoscopic response at two years
More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Nearly 90% of ...
standardmedia.co.ke4h
PPR: Why vaccination is only way out
Vaccination is a very important intervention in animal health, especially in disease prevention. There are many diseases ...